TNON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Tenon Medical Inc (TNON) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown revenue growth and improved gross margins, the negative EPS trend and lack of significant trading or news catalysts suggest limited immediate upside. Additionally, technical indicators do not provide a compelling entry point, and no proprietary trading signals are present today.
The MACD is positive and expanding (0.0201), which is a bullish sign, but RSI at 64.67 is neutral, suggesting no clear momentum. Moving averages are converging, indicating indecision in the market. The pre-market price is $0.8362, down -2.42%, with key resistance at $0.867 and support at $0.706.
Revenue increased by 32.24% YoY, and gross margin improved significantly by 39.83%, indicating operational efficiency.
No recent news or significant trading trends from hedge funds or insiders.
In Q3 2025, revenue increased to $1,173,000 (up 32.24% YoY), net income improved slightly but remains negative at -$3,339,000 (up 4.87% YoY), EPS dropped to -0.4 (down -88.98% YoY), and gross margin improved to 65.9% (up 39.83% YoY).
No data available for analyst ratings or price target changes.
